ArticleClinical case reports2025
Rhino-Orbital-Cerebral Mucormycosis in a Patient With Chronic Hepatitis B and D Coinfection: A Rare Case Report.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Rhino-Orbital-Cerebral Mucormycosis in a Patient With Chronic Hepatitis B and D Coinfection: A Rare Case Report.Clinical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rhino-orbital-cerebral mucormycosis (ROCM) is a rare but highly lethal fungal infection that typically occurs in patients with classical immunosuppressive states. This report presents a case of ROCM in a 27-year-old male whose sole systemic risk factor was chronic Hepatitis B (HBV) and Hepatitis D (HDV) coinfection. The patient presented with advanced disease, including nasal necrosis and progressive periorbital swelling. Advanced imaging revealed extensive intraorbital and intracranial invasion with significant mass effect, a finding that rendered the standard-of-care surgical debridement prohibitively high risk. A definitive diagnosis was established via histopathology. Consequently, a deliberate decision was made to proceed with exclusive medical management. The patient was treated successfully with high-dose intravenous liposomal amphotericin B monotherapy, resulting in a favorable clinical outcome. This case establishes chronic viral hepatitis as a significant non-classical risk factor for ROCM and provides critical evidence that aggressive medical monotherapy can serve as a definitive, life-saving treatment when the standard bimodal surgical approach is contraindicated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.